Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

Q3 2025 Results Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsCorey Davis - Investor Relations, ...

Palisade Bio presented a poster titled "PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug, Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model” at the Crohn's & Colitis Congress ...

Find out how an organisation adapted its in-person paediatric basic life support training to an online e-learning programme.

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Health systems are hopeful legal and potential congressional challenges will overturn the regulation, which will increase costs tied to most filings.

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...